On the heels of the Teladongo deal, more exits abound. Amwell and GoodRx have filed to go public, each with a somewhat surprising trajectory: Amwell with a $100M investment from Google Cloud and GoodRx with a track record of profits. Meanwhile, Amazon has moved into the wearable market with its Halo tracker, taking on juggernauts Apple and Fitbit. There's no word yet on whether the new tracker can detect symptoms of COVID-19. Unsurprisingly, wearables will play a vital role in back to work strategies—check out our take on how digital health is helping people return to work and school safely.
Rock Health Summit is less than a month away! Latest additions to the lineup include Best Buy CMO Daniel Grossman and Walmart SVP Marcus Osborne who will be taking the stage to talk about retail’s transformative moves into healthcare. Check out the full agenda here and see if you qualify for a discounted ticket.
Make Room In Your Wallet: Abbott Released A Card-Sized COVID-19 Test
The $5 rapid antigen test joins the back to work market FierceBiotech | (Tweet)
Organizations Won’t Let Mobile Data Protection Slip Through Cracks
Consumer Privacy Framework aims to protect your health data mHealthIntelligence | (Tweet)
Scientists Choose To Collaborate, Not Compete, On COVID-19 Research
A shared platform could be the key to answering questions Healthcare IT News | (Tweet)
Verily Enters Stop-Loss Insurance Market With New Subsidiary
Can tech-based underwriting help Verily differentiate themselves in the market? CNBC | (Tweet)
Is Face-To-Face Care Delivery A Thing Of The Past?
And is our healthcare system ready for a long-term shift to virtual? MedCity News | (Tweet)